¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Latitude Diabetes System Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • somatosensory system
    ¸ö°¨°¢°èÅë, ü¼º°¨°¢°è
  • static system
    Á¤Áö°è
  • scavenging system
    Á¦°Åü°è, û¼Òü°è
  • stereotactic system
    1. Á¤À§°íÁ¤±â 2. Á¤À§Ã¼°è, ÀÔüü°è
  • superficial musculo-aponeurotic system
    ¾ó±¼³ÎÈûÁÙ°èÅë, Ç¥Àç±Ù°Ç¸·°èÅë
  • superficial musculo-aponeurotic system platysma flap
    ¾ó±¼³ÎÈûÁÙ°èÅë³ÐÀº¸ñ±ÙÆÇ, Ç¥Àç±Ù°Ç¸·°èÅëȰ°æ±ÙÆÇ
  • system
    1. °èÅë, °è, ü°è 2. ÀåÄ¡ 3. Á¦µµ, ¹ý 4. ºÐ·ù¹ý
  • system analysis
    °èÅëºÐ¼®
  • self-system
    ÀÚ±âü°è
  • skeletal system
    »À´ë°èÅë, °ñ°Ý°è
  • social security system
    »çȸº¸ÀåÁ¦µµ
  • urinary system
    ºñ´¢°èÅë, ºñ´¢°è
  • urogenital system
    ºñ´¢»ý½Ä±â°èÅë, ºñ´¢»ý½Ä±â°è
  • vascular system
    Ç÷°ü°èÅë, Ç÷°ü°è
  • vegetative nervous system
    ½Ä¹°½Å°æ°èÅë, ½Ä¹°½Å°æ°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • local health system
    Áö¹æÀÇ·áü°è
  • lymphatic system
    ¸²ÇÁ°èÅë
  • macrophage system
    Å«Æ÷½Ä¼¼Æ÷°èÅë
  • major histocompatibility system
    ÁÖÁ¶Á÷ÀûÇÕ°è
  • metric system
    ¹ÌÅ͹ý
  • monocyte-macrophage cell system
    ´ÜÇÙ±¸Å«Æ÷½Ä¼¼Æ÷°èÅë
  • musculoskeletal system
    ±ÙÀ°°ñ°Ý°èÅë
  • nervous system
    ½Å°æ°èÅë
  • nonrecirculating system
    ºñÀç¼øÈ¯½Äȸ·Î
  • nonspecific sensory system
    ºñƯÁ¤°¨°¢°è
  • oil immersion system
    À¯Ä§ÀåÄ¡
  • open system
    °³¹æÁ¦, °³¹æ½Ã½ºÅÛ, °³¹æÇüº´¿ø
  • optical system
    ±¤Çаè
  • oscillating system
    Áøµ¿°è
  • oxidation-reduction system
    »êȭȯ¿ø°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • impulse conduction system
    ÈïºÐÆÄÀüµµ°è.
  • impulse conduction system
    ÈïºÐÆÄÀüµµ°è(ýéÝÇ÷îîîÓôͧ).
  • inference system
    ÃßÃø°è
  • infusion-aspiration system
    ÁÖÀÔÈíÀÔÀåÄ¡
  • pituitary adrenal system
    ÇϼöüºÎ½ÅÇÇÁú°è(¡­Üùãìù«òõͧ).
  • pituitary portal system
    ³úÇϼöü¹®¸Æ°è(¡­Ú¦ØæÍ§).
  • pneumatic tube system
    ±â¼Û°üÀåÄ¡(ѨáêηíûöÇ)
  • portal system
    ¹®¸Æ°è(Ú¦ØæÍ§).
  • pressoreceptor nervous system
    ¾Ð·Â¼ö¿ë½Å°æ°è(¡­ãêÌèͧ).
  • pride system
    ÀÚ±àü°è£¨í»Ðèô÷ͧ£©
  • primary signal system
    ÀÏÂ÷½ÅÈ£°è(ìéó­ãáûÜ Í§).
  • primary signalling system
    ÀÏÂ÷Àû¡¡½Åȣü°è
  • primitive duct system
    ¿ø½Ã°ü°èÅë
  • projective system
    Åõ»çü°è
  • real time system
    ½Ç½Ã°£ ü°è
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • cardiac conducting system
    ½ÉÀåÀüµµ°èÅë
  • cardiac conduction system
    ½ÉÀå ÈïºÐ Àüµµ°è(ãýíôýéÝÇîîÓôͧ)
  • cardiovascular system
    ½ÉÇ÷°ü°è(ãýúìμÌõ)
  • cardiovascular system
    ½ÉÇ÷°ü°è(ãýúìηͧ)
  • cardiovascular system
    ¼øÈ¯°èÅë
  • case payment system
    Æ÷°ý¼ö°¡Á¦
  • central nervous system
    ÁßÃ߽Űæ°è(ñéõÒãêÌèͧ)
  • central nervous system
    ÁßÃ߽Űæ°èÅë, ÁßÃ߽Űæ°è(ñéõÒãêÌèͧ).
  • central nervous system
    ÁßÃ߽Űæ°èÅë
  • central nervous system =CNS
    ÁßÃ߽Űæ°è(Åë).
  • central nervous system=CNS
    ÁßÃ߽Űæ°è
  • central piping system
    Áß¾Ó¹è°ü½Ã¼³
  • central piping system
    Áß¾Ó¹è°ü½Ã¼³<¼³ºñ>(Ì¡ËâËÑË´ËàËÛ<ËÛËÓ>).
  • centrencephalic system
    Á߽ɳú°è(ñéãýÒàͧ).
  • cerebrospinal system
    ³úô¼ö°è(Òàô±âÐͧ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
AOD Academy of Operative Dentistry; Academy of Oral Dynamics; adult onset diabetes; anesthesiologist-on-...
AODM adult onset diabetes mellitus
AREDYLD acrorenal field defect, ectodermal dysplasia, lipoatrophic diabetes [syndrome]
DAP data acquisition processor; depolarizing afterpotential; diabetes-associated peptide; diaminopimelic...
DB data base; date of birth; deep breath; dense body; dextran blue; diabetes, diabetic; diagonal band; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
T1DM Type 1 diabetes mellitus
T2DM Type 2 diabetes mellitus
UKPDS UK Prospective Diabetes Study
UKPDS United Kingdom Prospective Diabetes Study
AMS AUTO-MICROBIC-SYSTEM
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pain system
    µ¿Åë°è
  • pain transmission system
    µ¿Åë Àü´Þ°è
  • pain-modulating system
    µ¿Åë Á¶Àý°è
    ÁßÃß ½Å°æ°è´Â Åë°¢À» Àü´ÞÇÏ¿© ÅëÁõÀ» ´À³¢°Ô ÇÏ´Â ±â´É À̿ܿ¡µµ µ¿ÅëÀ» ÅëÁ¦ÇÏ´Â ÀÏ·ÃÀÇ ½Å°æ Á¶Á÷À» °®°í ÀÖÀ¸¸ç, ½Å°æ ¼¼Æ÷¿¡¼­ o
  • pallidal system
    ´ãⱸ°è
  • palm and sole system of identification
    ¼öÀå Á·Àú È®Àιý
  • peripheral nervous system
    ¸»ÃÊ ½Å°æ°è
    1. ³ú ½Å°æ, ô¼ö ½Å°æ, ÀÚÀ² ½Å°æ. 2. ³ú¿Í ô¼ö ¹Ù±ù¿¡ ÀÖ´Â ¿îµ¿ ¹× °¨°¢ÀÇ ±³°¨½Å°æ°ú ºÎ±³°¨½Å°æ.
  • peripheral pain sensory system
    ¸»Ãʼº Åë°¢°è
  • peripheral vascular system
    ¸»ÃÊÇ÷°ü°è
  • pindex system technique
    Çɵ¦½º¹ý
  • pituitary adrenal system
    Çϼöü ºÎ½Å ÇÇÁú°è
  • primary signalling system
    ÀÏÂ÷Àû¡¡½Åȣü°è Á¤½Å
  • psychological modulation system
    ½É¸®Àû Á¶Àý ü°è
  • Q : Àü±â·®ÀÇ coulombÀÇ ±âÈ£.

    Q blood group system

    Å¥½Ä Ç÷¾×Çü
    Ç÷¾×ÇüÀÇ Çϳª. µÅÁö Ç÷ûÀÇ ¾î¶² °Í¿¡ Á¸ÀçÇÏ´Â Ç× Q ÀÀÁý¼Ò¸¦ °¡ÇßÀ» ¶§ ÀÀÁýÇϴ°¡ ÇÏÁö ¾Ê´Â°¡¿¡ µû¶ó Ç÷¾×À» ºÐ·ùÇÏ´Â °ÍÀÌ´Ù. Ç× QÀÀÁý¼Ò´Â P½Ä Ç÷¾×ÇüÀÇ Ç× P ÀÀÁý¼Ò¿Í µ¿ÀÏÇÑ °ÍÀ̶ó´Â Çм³µµ ÀÖ´Ù.
  • renal depressor system
    ½Å °­¾Ð°è
  • renal pressor system
    ½Å ½Â¾Ð°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
pedal system Efferent fibres connecting the forebrain with more caudal structures.
(05 Mar 2000)
central nervous system <anatomy, neurology> Pertaining to the brain, cranial nerves and spinal cord. It does not include muscles or peripheral nerves.
In invertebrates, the central nervous system is composed of the segmental ganglia of the ventral nerve cord together with the fused ganglia or brain at the anterior end.
Acronym: CNS
(12 Jan 1998)
central nervous system agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "non-specific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with non-specific mechanisms are generally further classed according to whether they produce behavioural depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use.
(12 Dec 1998)
central nervous system depressants A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anaesthetics, hypnotics and sedatives, narcotics, and tranquillising agents (antipsychotics and antianxiety agents).
(12 Dec 1998)
central nervous system infections Diseases of the central nervous sytem collectively, caused by pathogenic organisms.
(12 Dec 1998)
central nervous system neoplasms Neoplasms located in the brain, spinal cord, or meninges.
(12 Dec 1998)
central nervous system stimulants A loosely defined group of drugs that tend to increase behavioural alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
(12 Dec 1998)
glycogen debranching enzyme system 1,4-alpha-d-glucan-1,4-alpha-d-glucan 4-alpha-d-glucosyltransferase/dextrin 6 alpha-d-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (ec 2.4.1.25) and amylo-1,6-glucosidase (ec 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-d-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-d-glucan. As a glucosidase it catalyses the endohydrolysis of 1,6-alpha-d-glucoside linkages at points of branching in chains of 1,4-linked alpha-d-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.
(12 Dec 1998)
respiratory system The organs that are involved in breathing. These include the nose, throat, larynx, trachea, bronchi, and lungs.
(12 Dec 1998)
respiratory system abnormalities Congenital structural abnormalities of the respiratory system.
(12 Dec 1998)
respiratory system agents Drugs used for their effects on the respiratory system.
(12 Dec 1998)
reticular activating system <physiology> A physiological term denoting that part of the brainstem reticular formation that plays a central role in the organism's bodily and behavorial alertness.
It extends as a diffusely organised neural apparatus through the central region of the brainstem into the subthalamus and the intralaminar nuclei of the thalamus; by its ascending connections it affects the function of the cerebral cortex in the sense of behavioural responsiveness; its descending (reticulospinal) connections transmit its activating influence upon bodily posture and reflex mechanisms (e.g., muscle tonus), in part by way of the gamma motor neurons.
See: reticular formation.
Synonym: non-specific system.
(05 Mar 2000)
reticuloendothelial system The phagocytic system of the body, including the fixed macrophages of tissues, liver and spleen. Rather old fashioned term that is coming back into use, mononuclear phagocyte system is probably better when only phagocytes are meant.
(18 Nov 1997)
cerebrospinal system The combined central nervous system and peripheral nervous system.
(05 Mar 2000)
charge transfer system A complex between two organic molecules in which an electron from one (the donor) is transferred to the other (the acceptor), becoming generally distributed throughout the latter; subsequent transfer of a hydrogen atom completes the reduction of the acceptor; such complex's are generally highly coloured and may be so observed, a network of hydrogen bridges at the catalytic centre of certain proteases.
Synonym: charge transfer system.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • truck system
    (ÀÓ±ÝÀÇ) Çö¹° Áö±ÞÁ¦
  • twoparty system
    2´ë Á¤´çÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á